polycistronic IL-12 immune modulator plasmids (Oncosec Medical/Fred Hutchinson Cancer Research Center)

N/A

Report date: 2025/06/11 20:01:15

Base Information

Drug Namepolycistronic IL-12 immune modulator plasmids (Oncosec Medical/Fred Hutchinson Cancer Research Center)
Drug Alias NamePlasmid based immunotherapy (Oncosec Medical/Fred Hutchinson Cancer Research Center)PIIM-NYESO1PIIM-OVA
ClassificationCell and gene therapy > Gene therapy > Plasmid
Mechanisms of ActionImmunomodulatorsInterleukin-12 gene modulators
TargetsInterleukin-12
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesOncosec Medical Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesOncosec Medical IncFred Hutchinson Cancer Research Center
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A